MEDS (DataMEDS AI) Tariff Resilience Score: 5/10 (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DataMEDS AI Tariff Resilience Score?

DataMEDS AI MEDS -3.35% Tariff Resilience Score is 5 as of Jul. 26, 2026. The stock has 6 warning signs investors should review. Among 121 Medical Distribution companies, DataMEDS AI ranks better than 92.56% on this metric.

DataMEDS AI has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

DataMEDS AI has Wellgistics Health imports a substantial portion of its products, making it vulnerable to tariffs. However, its focus on essential health products may offer some tariff exemptions. The company is exploring alternative suppliers to mitigate risks.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes DataMEDS AI might have Average Resilient.

DataMEDS AI  (NAS:MEDS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

DataMEDS AI Tariff Resilience Score Related Terms

MEDS vs HEWA, BLMH, PMHS: Tariff Resilience Score Comparison

For the Medical Distribution subindustry, DataMEDS AI's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DataMEDS AI Tariff Resilience Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, DataMEDS AI's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where DataMEDS AI's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 5 mean?
DataMEDS AI (MEDS) has a Tariff Resilience Score of 5 as of Jul. 26, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, DataMEDS AI ranks #9 out of 121 companies in the Medical Distribution industry, placing it in the top 7.4%.
Is DataMEDS AI's Tariff Resilience Score too high?
DataMEDS AI's current Tariff Resilience Score is 5. Based on the distribution chart, DataMEDS AI ranks #9 out of 121 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers.
How does DataMEDS AI's Tariff Resilience Score compare to HEWA and BLMH?
According to the Medical Distribution industry distribution chart, DataMEDS AI ranks #9 out of 121 companies for Tariff Resilience Score. This places DataMEDS AI in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Distribution company?
A good Tariff Resilience Score depends on the Medical Distribution industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. DataMEDS AI's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DataMEDS AI stock overvalued right now?
DataMEDS AI (MEDS) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For DataMEDS AI (MEDS), the current Tariff Resilience Score is 5 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DataMEDS AI Business Description

Address 3000 Bayport Drive, Suite 950, Tampa, FL, USA, 33607
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.